Sugi Predict

Sugi Predict / Compounds / SCHEMBL306639

SCHEMBL306639

SCHEMBL306639

CC(C)Oc1ccc([N+](=O)[O-])cn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSPB1 P04792 2/20 0.53
▸ KMT2A Q03164 5/20 0.50
▸ MEN1 O00255 4/20 0.50
▸ ALDH1A1 P00352 3/20 0.50
▸ PABPC1 P11940 2/20 0.50
▸ MAPT P10636 4/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ GAA P10253 2/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ CYP2C19 P33261 1/20 0.45
▸ CYP1A2 P05177 1/20 0.44
▸ POLB P06746 1/20 0.43
▸ RAB9A P51151 4/20 0.43
▸ NPC1 O15118 3/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ GABRA5 P31644 1/20 0.42
▸ HSP90AA1 P07900 1/20 0.42
▸ CXCR5 P32302 1/20 0.42
▸ APLNR P35414 1/20 0.42
▸ CCR6 P51684 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29199065 0.87 HSPB1 (0.50) HSPB1KMT2AMEN1ALDH1A1PABPC1
SCHEMBL11590 0.83 MAPT (0.52) HSPB1KMT2AMEN1ALDH1A1PABPC1
SCHEMBL745282 0.83 MAPT (0.52) HSPB1KMT2AMEN1ALDH1A1PABPC1
SCHEMBL29974305 0.83 HSPB1 (0.56) HSPB1KMT2AMEN1ALDH1A1PABPC1
SCHEMBL558792 0.83 HSPB1 (0.56) HSPB1KMT2AMEN1ALDH1A1PABPC1
SCHEMBL1978862 0.80 HSPB1 (0.54) HSPB1KMT2AMEN1ALDH1A1PABPC1
SCHEMBL30850667 0.80 KMT2A (0.70) HSPB1KMT2AMEN1PABPC1MAPT
SCHEMBL1851173 0.80 KMT2A (0.70) HSPB1KMT2AMEN1PABPC1MAPT
SCHEMBL5799 0.80 HSPB1 (0.54) HSPB1KMT2AMEN1ALDH1A1PABPC1
SCHEMBL27449389 0.80 HSPB1 (0.70) HSPB1KMT2AMEN1ALDH1A1PABPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113979928-B Preparation method of 2-chloro-5-nitropyridine 蚌埠中实化学技术有限公司 2023-09-05 — — CN claimed
CN-113979928-A Preparation method of 2-chloro-5-nitropyridine 蚌埠中实化学技术有限公司 2022-01-28 — — CN claimed
US-20250304571-A1 BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF SUZHOU KEEN THERAPEUTICS CO., LTD. (CN) 2025-10-02 — — US disclosed
EP-4565588-A1 BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF Suzhou Keen Therapeutics Co., Ltd. (CN) 2025-06-11 — — EP disclosed
WO-2023241620-A1 BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF SUZHOU KEEN THERAPEUTICS CO., LTD. (CN) 2023-12-21 — — WO disclosed
CN-113979928-B Preparation method of 2-chloro-5-nitropyridine 蚌埠中实化学技术有限公司 2023-09-05 — — CN disclosed
CN-113979928-B Preparation method of 2-chloro-5-nitropyridine 蚌埠中实化学技术有限公司 2023-09-05 — — CN disclosed
US-11713320-B2 5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof BIOSPLICE THERAPEUTICS, INC. (US) 2023-08-01 — — US disclosed
US-11713320-B2 5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof BIOSPLICE THERAPEUTICS, INC. (US) 2023-08-01 — — US disclosed
US-20220402921-A1 5-HETEROARYL SUBSTITUTED INDAZOLE-3-CARBOXAMIDES AND PREPARATION AND USE THEREOF VICKERS-SPLICE CO-INVESTMENT LLC (KY) 2022-12-22 — — US disclosed
US-11433061-B2 Heteroaryl sulfonamides and CCR2/CCR9 CHEMOCENTRYX, INC. (US) 2022-09-06 — — US disclosed
EP-1673088-A1 1,1,1- TRIFLUORO-4-PHENYL-4-METHYL-2-(1H-PYRROLO¬2,3-C|PYRIDIN-2-YLMETHYL)PENTAN-2-OL DERIVATIVES AND RELATED COMPOUNDS AS GLUCOCORTICOID LIGANDS FOR THE TREATMENT OF INFLAMMATORY DISEASES AND DIABETES BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2006-06-28 — — EP disclosed
CN-1678321-A Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds RIGEL PHARMACEUTICALS INC (US) 2005-10-05 — — CN disclosed
US-20050176706-A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2005-08-11 — — US disclosed
WO-2005030213-A1 1,1,1-TRIFLUORO-4-PHENYL-4-METHYL-2-(1H-PYRROLO BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2005-04-07 — — WO disclosed
US-5811432-A Azaoxindole derivatives PFIZER INC (US) 1998-09-22 — — US disclosed
CN-1031053-C Azaoxindole derivatives PFIZER (US) 1996-02-21 — — CN disclosed
CN-1053065-A AZAOXINDOLE DERIVATIVES PFIZER (US) 1991-07-17 — — CN disclosed
WO-1991009598-A1 AZAOXINDOLE DERIVATIVES PFIZER INC. (US) 1991-07-11 — — WO disclosed
EP-0436333-A2 Azaoxindole derivatives PFIZER INC. (US) 1991-07-10 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050176706-A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof NR3C1, NR3C2, MC2R HSPB1 1588/4885KMT2A 4501/4885MEN1 1192/4885
US-11433061-B2 Heteroaryl sulfonamides and CCR2/CCR9 CCR2, CCR9, CCR1 HSPB1 2024/4885KMT2A 2475/4885MEN1 4873/4885
US-11713320-B2 5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof DYRK1A, WNT3, DYRK3 HSPB1 1376/4885KMT2A 3103/4885MEN1 3562/4885
US-20220402921-A1 5-HETEROARYL SUBSTITUTED INDAZOLE-3-CARBOXAMIDES AND PREPARATION AND USE THEREOF DYRK1A, WNT3, DYRK3 HSPB1 1376/4885KMT2A 3103/4885MEN1 3562/4885
US-20250304571-A1 BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF VHL, BRCA1, TERT HSPB1 2560/4885KMT2A 1604/4885MEN1 301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.